CO-FOUNDER, CEO, IMMUNOGENX
WHY: Runs early-stage drug developer working on clinical trials of celiac disease. Thinks its core product could be the answer to millions of people suffering from the as-of-yet incurable digestive ailment that destroys the lining of the intestine.
NOTABLE: In 2011, sold his Tustin-based company Syagen Technology Inc., a provider of chemical analysis instruments to detect explosives carried by airline passengers, to French company Safran.
OC LEADER BOARD, MAY 11: After statistical analysis of early trends in the pandemic’s spread, said “we are fortunate in California and especially OC by escaping the worst of the COVID-19 epidemic.”
